Results 271 to 280 of about 109,288 (332)

A novel approach to target a challenging arrhythmia: Noninvasive electrocardiographic imaging mapping-guided ablation of swallowing-induced atrial tachycardia. [PDF]

HeartRhythm Case Rep
Batul SA, Shivamurthy P, Reddy VY, Koruth JS.   +3 more
europepmc   +1 more source

2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias [PDF]

, 2019
Cuculich, Phillip, et al,
core   +1 more source

Supraventricular Tachycardia Ablation in the Elderly—Characteristics and Outcomes

Journal of Arrhythmia, Volume 42, Issue 1, February 2026.
This single‐center retrospective study found that supraventricular tachycardia (SVT) ablation is safe and effective in younger and elderly patients. It should be considered for all symptomatic individuals regardless of age. However, the type of SVT and the presence of comorbidities, including frailty, should be considered in the clinical decision ...
Yi Yi Chua, Julian Cheong Kiat Tay, Eric Tien Siang Lim, Germaine Jie Min Loo, Wei Sheng Jonathan Ong, Xuanming Pung, Daniel Thuan Tee Chong, Kah Leng Ho, Chi Keong Ching   +8 more
wiley   +1 more source

Suspected pro‐arrhythmic effects of flecainide and the limitations of in‐hospital short‐duration electrocardiography in detecting ventricular arrhythmia burden in a dog with dilated cardiomyopathy

Veterinary Record Case Reports, Volume 14, Issue 1, February 2026.
Abstract A 10‐year‐old, female, spayed Pitbull mix presented for evaluation of an arrhythmia. Echocardiography revealed enlargement of all cardiac chambers and decreased left ventricular systolic function. Electrocardiography demonstrated isolated, ventricular premature complexes.
Nathan Mitchell, Tamilselvam Gunasekaran, Robert Sanders, Joanne DeSana   +3 more
wiley   +1 more source

Characterizing the recurrence of atrial arrhythmia following macro-reentrant atrial tachycardia ablation in adult patients with repaired tetralogy of Fallot. [PDF]

Heart Rhythm O2
Pinsker BL, Lin AL, Serfas JD, Spector ZZ, Piccini JP, Campbell MJ, Krasuski RA.   +6 more
europepmc   +1 more source

Extrasystoles on 24‐h Holter Monitoring During the First Year of Life

Acta Paediatrica, Volume 115, Issue 2, Page 370-377, February 2026.
ABSTRACT Aim To assess the natural course of extrasystoles and their association with tachyarrhythmias on 24‐h Holter monitoring during the first year of life. Methods A retrospective chart review was performed among newborns referred for 24‐h Holter monitoring at Tampere University Hospital from 2011 to 2017.
Asta Uusitalo, Päivi H. Korhonen, Antti Tikkakoski, Pieta Lehtinen, Kaisa Ylänen, Tuija Poutanen   +5 more
wiley   +1 more source

Direct Epicardial Mapping and Ablation Revealing Three-Dimensional Roof-Dependent Macroreentrant Atrial Tachycardia Breaking Into Bachmann's Bundle. [PDF]

Clin Case Rep
Suzuki Y, Takami K, Akita T, Nomura T, Fukuzawa K, Yoshida A.   +5 more
europepmc   +1 more source

Sodium glucose co‐transporter 2 inhibitors versus dipeptidyl peptidase‐4 inhibitors and the risk of ventricular arrhythmia among patients with type 2 diabetes: A population‐based cohort study

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 935-945, February 2026.
Abstract Aims To determine whether sodium glucose co‐transporter 2 inhibitors (SGLT2i) use, compared with dipeptidyl peptidase‐4 inhibitors (DPP4i) use, is associated with the risk of ventricular arrhythmias (VA) among patients with type 2 diabetes. Materials and Methods We conducted a population‐based cohort study using a prevalent new‐user design and
Wang‐Choi Tang, Pauline Reynier, Antonios Douros, Oriana H. Y. Yu, Robert W. Platt, Kristian B. Filion   +5 more
wiley   +1 more source

Cardiovascular Challenges in Chronic Lymphocytic Leukemia (CLL) Patients Undergoing Bruton Tyrosine Kinase (BTK) Inhibitor Therapy

European Journal of Haematology, Volume 116, Issue 2, Page 104-115, February 2026.
ABSTRACT Background/Objectives Bruton tyrosine kinase inhibitors (BTKis) have revolutionized treatment for chronic lymphocytic leukemia (CLL), but cardiovascular (CV) toxicities pose significant challenges. Second‐generation BTKis offer improved target specificity, yet CV risks persist.
Stefano Oliva, Stefano Molica
wiley   +1 more source